In vitro effect of hCG on cryptorchid patients’ gubernacular cells: a predictive model for adjuvant personalized therapy
The study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Ethics Committee of "Azienda Ospedaliera Universitaria Integrata" (AOUI) of Verona, Italy ("ANDRO-PRO", protocol code N. 4206 CESC of 26 April 2023).
Authors
- Giulia Ambrosini (ORCID: https://orcid.org/0000-0003-4210-8610)
- Filippo Migliorini (ORCID: https://orcid.org/0000-0001-7220-1221)
- Daniela Cecconi (ORCID: https://orcid.org/0000-0002-7314-8941)
- Andrea Errico (ORCID: https://orcid.org/0009-0003-9333-552X)
- Ilaria Dando (ORCID: https://orcid.org/0000-0002-6390-4184)
- Ilaria Decimo (ORCID: https://orcid.org/0000-0002-6627-1263)
- Nicola Zampieri (ORCID: https://orcid.org/0000-0002-0296-3789)
- Elisa Dalla Pozza (ORCID: https://orcid.org/0000-0001-6813-5436)
- Jessica Brandi (ORCID: https://orcid.org/0000-0003-1643-7023)
- Emanuela Bottani (ORCID: https://orcid.org/0000-0003-1217-8722)
- Nunzio Marroncelli (ORCID: https://orcid.org/0009-0003-7711-9640)
- Sara Vinco (ORCID: https://orcid.org/0009-0005-3701-0936)
Institutions
- University of Verona (IT)
- Azienda Ospedaliera Universitaria Integrata Verona (IT)
- Saint Camillus International University of Health and Medical Sciences (IT)
Publication Details
- Journal
- Cell Communication and Signaling
- Published
- 2025-01-10
- DOI
- https://doi.org/10.1186/s12964-024-01979-y
- Citations
- 4
- Primary Topic
- Testicular diseases and treatments
- Type
- article
- Field-Weighted Citation Impact
- 8.03
Funders
- Ministero dell’Istruzione, dell’Università e della Ricerca
- Università degli Studi di Verona